Schulze LL, Becker E, Dedden M, Liu LJ, et al. Differential Effects of Ontamalimab Versus Vedolizumab on Immune Cell Trafficking in Intestinal Inflammation and Inflammatory Bowel Disease. J Crohns Colitis 2023;17:1817-1832.
PMID: 37208197